MedImmune: changing the US licensing landscape
This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight
The recent United States Supreme Court decision in MedImmune v Genentech significantly changed the law governing the challenge of patent licences in the United States
Download